REXR 241220 50.00P (REXR241220P50000) Stock Options, News & Quotes

7.70
0.000.00%

15min DelayClose Nov 29 13:00 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Feb 5 15:11

The Co-CEOs of the company, Michael Frankel and Howard Schwimmer, expressed their commitment to driving long-term shareholder value and stated their focus on executing value creation strategies for the benefit of their shareholders.

Press Release: Rexford Industrial Announces 10 Percent Increase in Quarterly Common Stock Dividend

Analysts Notebook

Jun 12, 2023 07:30

Columns US Top Rating Updates on 6/12: AZO, ORCL, BILL, KMX and More

$ArcBest (ARCB.US)$ initiated at buy by Jefferies, announced target price at $110.00.
$Saia (SAIA.US)$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone (AZO.US)$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle (ORCL.US)$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings (BILL.US)$ was downg...

Analysts Notebook

Jun 21, 2022 06:06

Columns Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more

Upgrades
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...

Moomoo Breakfast US

Apr 6, 2022 07:42

Columns Today's pre-market stock movers: ARRY, RIOT, MRNA, NVAX and more

Gainers:
• $Array Technologies (ARRY.US)$ +12.87% (also names new CEO)
• $Tufin Software Technologies (TUFN.US)$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals (CTXR.US)$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics (BTAI.US)$ +19.22% (FDA ha...